Sanara Medtech Stock Analysis

Sanara Stock Analysis Notes

About 67.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.99. Sanara Medtech last dividend was issued on the 10th of May 2019. The entity had 1:100 split on the 10th of May 2019. Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 63 people. To find out more about Sanara Medtech contact the company at 817 529 2300 or learn more at https://sanaramedtech.com.

Sanara Medtech Investment Alerts

Sanara Medtech Upcoming and Recent Events

Sanara Largest EPS Surprises

View All Earnings Estimates

Sanara Medtech Environmental, Social, and Governance (ESG) Scores

Sanara Stock Institutional Investors

Note, although Sanara Medtech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sanara Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 302.88 M.

Sanara Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.

Management Efficiency

Sanara Medtech has return on total asset (ROA) of (0.0508) % which means that it has lost $0.0508 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2028) %, meaning that it created substantial loss on money invested by shareholders. Sanara Medtech's management efficiency ratios could be used to measure how well Sanara Medtech manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.16. The current Return On Capital Employed is estimated to decrease to -0.07. As of now, Sanara Medtech's Total Current Assets are increasing as compared to previous years. The Sanara Medtech's current Intangible Assets is estimated to increase to about 54.2 M, while Non Currrent Assets Other are forecasted to increase to (16.3 M).

Technical Drivers

As of the 21st of March, Sanara Medtech has the Coefficient Of Variation of (21,433), risk adjusted performance of 0.0028, and Variance of 8.35. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sanara Medtech, as well as the relationship between them.

Sanara Medtech Price Movement Analysis

Sanara Medtech Insider Trading Activities

Sanara Medtech Outstanding Bonds

Sanara Medtech Predictive Daily Indicators

Sanara Medtech Corporate Filings

Sanara Medtech Forecast Models

Sanara Medtech's time-series forecasting models are one of many Sanara Medtech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sanara Medtech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sanara Medtech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sanara shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sanara Medtech. By using and applying Sanara Stock analysis, traders can create a robust methodology for identifying Sanara entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sanara analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sanara analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Sanara Medtech stock analysis indicators help investors evaluate how Sanara Medtech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sanara Medtech shares will generate the highest return on investment. By understating and applying Sanara Medtech stock analysis, traders can identify Sanara Medtech position entry and exit signals to maximize returns.

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.